GenoGenix recalls BPC-157/Thymosin Beta-4 injections due to lack of sterility assurance. Affected lots include GG020525-001, GG060525-001, GG062625-004. No remedy specified in recall notice.
Lack of Assurance of Sterility
GenoGenix is recalling BPC-157/Thymosin Beta-4 injections that may not be sterile. This could lead to infections if used. The recall covers specific lots and sizes.
The injections lack assurance of sterility, meaning they might contain harmful bacteria or other contaminants. If used, this could cause infections or other health issues.
People who have received the recalled BPC-157/Thymosin Beta-4 injections from GenoGenix. Those using the product for medical treatments are most at risk.
Check the lot numbers: GG020525-001, GG060525-001, GG062625-004. The product is labeled as BPC-157/Thymosin Beta-4 for Injection, 10/10mg, 15/15mg, or 15mg/15mg.
Look for lot numbers GG020525-001, GG060525-001, or GG062625-004 on the injection packaging.
BPC-157/Thymosin Beta-4 injections in 10/10mg, 15/15mg, and 15mg/15mg presentations.
Lack of assurance of sterility, which could lead to infections if the product is used.
The recall notice does not specify a remedy, so contact GenoGenix for guidance.
We’ve drafted a message you can send GenoGenix to request your refund or repair — edit it as you like.
Subject: Recall D-0086-2026 — GenoGenix GenoGenix Hello, I own a GenoGenix that is covered by recall D-0086-2026 from GenoGenix. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
